VRK1 and glioblastoma: Finally, the VRK1/YBX1/SOX2 pathway regulates the stemness and proliferation of GSCs, and the VRK1‐targeted nanoliposome A/TMZ‐siVRK1 effectively inhibits the stemness and proliferation of GSCs, highlighting its therapeutic potential in GBM (Figure 11).